Healthcare Industry News:  Balloon catheter 

Devices Orthopaedic Distribution

 News Release - January 30, 2014

IlluminOss Medical Announces Spanish and Israeli Launch of Photodynamic Bone Stabilization System (PBSS)

EAST PROVIDENCE, R.I.--(Healthcare Sales & Marketing Network)--IlluminOss Medical, a privately held, commercial stage medical device company pioneering the development of minimally invasive fracture fixation technologies, has launched its proprietary Photodynamic Bone Stabilization System (PBSS) in Spain and Israel. IlluminOss launched its PBSS, an innovative percutaneous, patient-specific orthopedic implant system for the stabilization and treatment of bone fractures, with Prim Ortopedia in Spain and in Israel with Trimaco, Ltd.

“We look forward to expanding access to this technology, which can significantly enhance how orthopedic fractures are treated, in Spain and Israel,” said Dirk Kuyper, president and CEO of IlluminOss. “We are now commercially available in eight countries, providing patients and surgeons with an innovative and unprecedented fracture repair system.”

With a CE Marking Certificate for light to low-load bearing indications, IlluminOss’ PBSS is being utilized in Germany, Austria, Switzerland, Italy, Turkey and The Netherlands, in addition to Spain and Israel. IlluminOss is seeking U.S. FDA approval as well as an expansion of its indications in the EU.

The minimally invasive PBSS enables clinicians to repair bone fractures using a light-curable polymer contained within an expandable Balloon catheter to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, customized method of orthopedic bone stabilization. The number of IlluminOss’ surgical implants continues to grow with excellent outcomes.

IlluminOss offers PBSS directly to providers in Germany, Austria and Switzerland through IlluminOss Medical GmbH. IlluminOss partners with Medikon in Turkey, Mikai S.P.A. in Italy, and Pro-Motion Group BV in the Netherlands.

About IlluminOss Medical

IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, Photodynamic Bone Stabilization System (PBSS). This minimally invasive technology allows for fracture fixation through patient specific intramedullary implants. The PBSS System utilizes a light-curable polymer, contained within an expandable Balloon catheter, to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of orthopedic bone stabilization. The company currently markets its products in international countries under a CE Mark for approved clinical applications through both a direct sales force and distribution networks. Founded in 2007, IlluminOss is headquartered in East Providence, RI, and funded by Foundation Medical Partners, New Leaf Venture Partners, Tekla Capital, Life Sciences Partners, SR One, Longwood Fund, Excel Venture Management, Pappas Ventures, Mieza Capital and Slater Technology. Learn more at www.illuminoss.com.

The IlluminOss products are Investigational Devices; limited by Federal law to Investigational Use and are not approved for sale in the United States.


Source: IlluminOss Medical

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.